Zelos Pipeline

Zelos is developing an innovative portfolio of complementary bone disease therapies covering osteoporosis, fracture repair, spine fusion and renal bone disease. Our focus on bone disease allows us to efficiently leverage our expertise to rapidly advance bone formation agents – specifically PTH analogs -  through development for each indication.

All Business Development inquiries should be addressed to:

Joan Lau
Chief Executive Officer
Zelos Therapeutics, Inc.
Four Tower Bridge
200 Barr Harbor Drive, Suite 400
West Conshohocken, PA  19428
Telephone:  (610) 260-6045
Fax: (610) 567-2044